H.E.L.P. Apheresis (Heparin-induced Extracorporeal LDL Precipitation) is an advanced blood filtration therapy that removes harmful substances from the bloodstream, including inflammatory proteins, autoantibodies, environmental toxins, and excess lipids.
H.E.L.P. Apheresis is a medical procedure that filters the blood to remove specific harmful substances. Originally developed for treating severe lipid disorders, it has proven effective for a wider range of conditions. The procedure can remove inflammatory cytokines, autoantibodies, spike proteins, environmental toxins, excess fibrinogen, and pathological lipoproteins from the blood in a single session.
Blood is drawn from one arm, mixed with heparin, and passed through a specialized filtration system. The system separates plasma from blood cells, then selectively removes targeted substances from the plasma using precipitation and filtration. The cleaned plasma is reunited with the blood cells and returned to the patient through the other arm. The entire process runs continuously in a closed circuit.
Our physicians will recommend specific treatments only after a thorough assessment.
A H.E.L.P. Apheresis session takes approximately 2-3 hours. The patient sits or reclines comfortably with IV access in both arms. The procedure is painless beyond the initial needle placement. Most patients report feeling lighter and more energetic after treatment. A series of sessions is typically recommended, with frequency determined by the underlying condition.
H.E.L.P. Apheresis is well-established in medical literature for lipid disorders and cardiovascular risk reduction. More recent research, particularly post-2020, has documented its effectiveness in removing spike proteins and inflammatory mediators in post-COVID patients. Multiple published studies support its use in reducing inflammatory burden and improving symptoms in chronic conditions.
Clinical findings by Dr. Beate Jaeger have demonstrated the ability of H.E.L.P. Apheresis to reduce fibrinoid microclots and improve microcirculation in Post-COVID patients. Her research provides evidence that targeted blood filtration can address the vascular and endothelial dysfunction commonly observed in long COVID, contributing to measurable improvements in fatigue, cognitive function, and exercise tolerance.
Contact our medical team to discuss whether this therapy may be appropriate for your condition.
